Schjødt has assisted Vaccibody on the transaction. Vaccibody entered into worldwide license and collaboration agreement with Genentech, a member of the Roche Group, to develop individualized neoantigen…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now